An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
Redbiotec has a right to royalties on Eurocine Vaccines´ net sales of an approved HSV-2 vaccine, should such sales arise.
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs
This agreement is in addition to the $92 million filling line expansion announced in November 2021
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
Includes thermostabilized Ebola vaccines
Subscribe To Our Newsletter & Stay Updated
